[go: up one dir, main page]

MX2018008793A - Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato. - Google Patents

Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.

Info

Publication number
MX2018008793A
MX2018008793A MX2018008793A MX2018008793A MX2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A MX 2018008793 A MX2018008793 A MX 2018008793A
Authority
MX
Mexico
Prior art keywords
beta
pharmaceutical
hydroxy
betamethylbutyrate
combination
Prior art date
Application number
MX2018008793A
Other languages
English (en)
Inventor
Sathyavageeswaran Shreeram
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2018008793A publication Critical patent/MX2018008793A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una combinación farmacéutica o nutricional que comprende beta-hidroxi beta-metilbutirato (HMB) y tetrahidrocurcumina (THC) y métodos que comprenden administrar la combinación a un sujeto. Los métodos de 5 la invención se refieren a atenuar la degradación de la proteína muscular y/o preservar la masa corporal magra en el sujeto.
MX2018008793A 2016-01-19 2017-01-16 Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato. MX2018008793A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1600990.4A GB201600990D0 (en) 2016-01-19 2016-01-19 Pharmaceutical or nutritional combination
PCT/US2017/013672 WO2017127333A1 (en) 2016-01-19 2017-01-16 Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate

Publications (1)

Publication Number Publication Date
MX2018008793A true MX2018008793A (es) 2018-11-09

Family

ID=55488189

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008793A MX2018008793A (es) 2016-01-19 2017-01-16 Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.

Country Status (9)

Country Link
US (1) US20210220301A1 (es)
EP (1) EP3405186A1 (es)
JP (1) JP2019501980A (es)
CN (1) CN108495624A (es)
CA (1) CA3011633A1 (es)
GB (1) GB201600990D0 (es)
MX (1) MX2018008793A (es)
SG (1) SG11201806127XA (es)
WO (1) WO2017127333A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP3855945A1 (en) * 2018-09-25 2021-08-04 Roquette Freres Food composition containing a mixture of leguminous proteins and casein
JP2020195286A (ja) * 2019-05-31 2020-12-10 株式会社東洋新薬 経口組成物
JP2021070643A (ja) * 2019-10-30 2021-05-06 小林製薬株式会社 筋肉量改善用組成物
US11872197B2 (en) * 2020-03-03 2024-01-16 Another Chance Nutra, LLC Method of treatment or alleviating symptoms of a disorder with curcumin
WO2026006879A1 (en) * 2024-07-03 2026-01-08 Clover Corporation Limited Formulations of hygroscopic materials

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110064712A1 (en) * 2009-09-16 2011-03-17 Daniel Moses Amato Dietary Supplement Compositions and Methods of Making and Using the Same
PH12013501385A1 (en) 2010-12-27 2013-09-02 Abbott Lab Methods for facilitating muscle recovery after a period of disuse betahydroxy-beta-methylbutyrate
WO2012097061A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
WO2014028607A1 (en) * 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics

Also Published As

Publication number Publication date
SG11201806127XA (en) 2018-08-30
EP3405186A1 (en) 2018-11-28
US20210220301A1 (en) 2021-07-22
CA3011633A1 (en) 2017-07-27
JP2019501980A (ja) 2019-01-24
WO2017127333A1 (en) 2017-07-27
GB201600990D0 (en) 2016-03-02
CN108495624A (zh) 2018-09-04

Similar Documents

Publication Publication Date Title
MX2018008793A (es) Combinacion farmaceutica o nutricional que comprende beta-hidroxi-betametilbutirato.
CO2019009234A2 (es) Composiciones terapéuticas inmunomoduladoras de arnm que codifican péptidos de activación de mutaciones oncogénicas
PH12019501010A1 (en) Arginase inhibitor combination therapies
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
BR112016024352A2 (pt) ?cepa de listeria recombinante, listeria recombinante, composição farmacêutica, e, métodos de induzir uma resposta imune contra um tumor ou um câncer em um indivíduo humano e de listeria?
PH12018502714A1 (en) Nicotine particles and compositions
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
SG10201809701TA (en) Peptide vaccine comprising mutant ras peptide and chemotherapeutic agent
MX2018014716A (es) Anticuerpos anti-tnfrsf25.
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
MX388724B (es) Composicion nutricional pediatrica con peptidos lacteos para un crecimiento y desarrollo saludable.
PH12017500450A1 (en) Flavivirus virus like particle
EA201592003A1 (ru) Микропищевые добавки для иммунитета
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
WO2015123493A3 (en) Compositions and methods for modulatuion of immune response
PH12018500772A1 (en) Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection
MX2020002585A (es) Inhibidor de hdac combinado con un modulador del punto de control inmunitario para la terapia contra el cancer.
EP4342544A3 (en) Enhancing the therapeutic activity of an immune checkpoint inhibitor
MX2019006446A (es) Métodos para inducir tolerancia inmunológica a factores de coagulación.
WO2015149016A3 (en) Breast and ovarian cancer vaccines
IL253791A0 (en) Doses and methods of administration of telavancin
MX2019014090A (es) Métodos para el tratamiento de la reservoritis crónica.
PH12017501979A1 (en) Pharmaceutical compound
ZA201904384B (en) Therapeutic method using tolerogenic peptides